Recon Top Stories Catalyst OrthoScience Announces 5-8 Year Data Reporting Significant Functional Improvement and Pain Reduction for Anatomic Total Shoulder Arthroplasty byTim AllenJune 4, 2025
Recon Catalyst OrthoScience Announces Leadership Transition: Miguel A. Ramirez, MD, Appointed Chief Medical Officer byJosh SandbergApril 2, 2025
Recon Regulatory Top Stories Catalyst OrthoScience Announces FDA 510(k) Clearance for Shoulder Fracture System and First Cases byJosh SandbergOctober 15, 2024
Financial Recon Top Stories Catalyst OrthoScience Surpasses 10,000 Total Shoulder Arthroplasty (TSA) Procedures and Announces $20 Million Financing byJosh SandbergSeptember 10, 2024
Extremities Catalyst OrthoScience Announces Amy Ables, Ph.D. as Chief Strategy Officer byJosh SandbergNovember 20, 2023
Recon Top Stories Catalyst OrthoScience Announces First Series of Procedures Using World’s Only Fully Convertible Stemmed CSR TSA System Featuring an Ellipsoid Humeral Head byJosh SandbergMay 25, 2023
Recon Research Published in JSES Indicates that the Catalyst™ CSR Total Shoulder System Outperforms Traditional Stemmed Implants byJosh SandbergMarch 6, 2023
Recon Regulatory Catalyst Receives FDA 510(k) Clearance for its Convertible Stemmed Total Shoulder Arthroplasty System byJosh SandbergFebruary 9, 2023
Extremities Recon Catalyst OrthoScience Announces Todd Wilson, PhD as Vice President of Medical Education and Training byChris StewartMay 18, 2022
Extremities Recon Catalyst OrthoScience Announces David Sharp as Vice President of Global Marketing byChris StewartApril 12, 2022
